US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 11:19:29 Source：Culture Chronicle news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
- Emma Weymouth channels wedding chic in a white gown at Cannes Film Festival
- Andrew Garfield looks loved
- Mexico's likely next president would be its first leader with a Jewish background
- A Palestinian baby in Gaza is born an orphan in an urgent cesarean section after an Israeli strike
- Wisconsin regulators investigating manure spill that caused mile
- Jokic, Gilgeous
- Los Angeles Mayor Karen Bass safe after suspect breaks into official residence, police say
- Los Angeles Mayor Karen Bass safe after suspect breaks into official residence, police say
- Devers sets Red Sox record by homering in his 6th consecutive game
- David Beckham's best pal Dave Gardner reveals guests at Victoria's star
- Rafael Devers sets team record by homering in 6th straight game as Red Sox top Rays 5
- Chinese museums receive 73 mln visits during Spring Festival holiday
- UK prosecutors charge 2 men with spying for China, including a parliamentary researcher
- Taylor Swift's Fortnight music video reunites Dead Poets Society stars Ethan Hawke and Josh Charles
- Massachusetts Senate weighs tuition
- Bride slammed for 'beige wedding' after telling guests what colours they could wear to ceremony
- Traffic resumes near Copenhagen’s Old Stock Exchange after a fire ruined the 400
- Miles Russell's historic week continues as 15
- At least 6 Egyptian women die after vehicle slides off ferry and plunges into Nile River
- The flooded housewives of Dubai: Chanel underwater, supercars swept away and mega
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Culture Chronicle news portal sitemap